(Q48593408)

13 February 2018

title

The cost effectiveness of B-Type natriuretic peptide measurement in the primary care setting-a UK perspective (English)

1 reference

13 February 2018

author name string

Paul O Collinson

series ordinal

1

1 reference

13 February 2018

publication date

1 March 2006

1 reference

13 February 2018

published in

Congestive Heart Failure

1 reference

13 February 2018

volume

12

1 reference

13 February 2018

issue

2

1 reference

13 February 2018

page(s)

103-107

1 reference

13 February 2018

Guidelines for the diagnosis and treatment of chronic heart failure

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04885.X

Management of chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04885.X

B-type natriuretic peptide in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04885.X

Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04885.X

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04885.X

Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04885.X

Biochemical detection of left-ventricular systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04885.X

Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04885.X

Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04885.X

Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04885.X

Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04885.X

Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04885.X

Evaluation of N-terminal pro-B type natriuretic peptide analysis on the Elecsys 1010 and 2010 analysers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04885.X

What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2006.04885.X

10.1111/J.1527-5299.2006.04885.X

21 January 2018

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018